
Bill Hinshaw
President & Chief Executive Officer
We are a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions. EMMs fundamentally impact and regulate metabolism, controlling many of the biological functions. At Axcella, we are seeking to unlock the full potential of EMMs by combining a deep understanding of biological pathways with recent advances in systems biology and machine learning. The end result: Multi-targeted EMM compositions with the potential to address the unmet medical needs of patients with a range of complex conditions.
President & Chief Executive Officer
President, Research and Development
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Legal Officer and Corporate Secretary
Senior Vice President, Chief People Officer
Senior Vice President, Chief Financial Officer
President & Chief Executive Officer
Executive Partner, Flagship Pioneering
Founder, CMR Pharma Consulting
Chief Executive Officer, Nestlé Health Science
Adjunct Professor, University of California San Francisco
Chief Financial Officer, Bluebird Bio
President, Moderna
Chief Medical Officer, Dicerna Pharmaceuticals, Inc.
Harry E. Figgie Professor of Business Administration, Harvard Business School
Whether you are a potential employee, business partner or investor, we want to hear from you.
Distinguished Service Professor & Higginson Professor of Physiology and Medicine, Harvard Medical School
Director, Sarah W. Stedman Nutrition and Metabolism Center Director, Duke Molecular Physiology Institute
Chief Medical Officer, Flagship Pioneering
Chief Executive Officer, Kallyope
Cleveland Family Professor of Pediatric Research Professor of Human Genetics University of Pittsburgh